RecruitingNCT05072626
High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
Study on High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia After Kasai Portoenterostomy
Sponsor
Children's Hospital of Fudan University
Enrollment
300 participants
Start Date
Oct 11, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This study is a prospective, single center and observational open clinical study.
Eligibility
Max Age: 3 Months
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with biliary atresia, infant, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include up to age 3 Months.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05072626
Related Trials
Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia
NCT07797673
Mapping Disease Pathways for Biliary Atresia
NCT032730491 location
Infants With Severe Acute Respiratory Distress Syndrome: The Prone Trial
NCT050024781 location
Automated Oxygen Control in Preterms on Non-invasive Ventilation
NCT07622563
Molecular Characterization for Understanding Biliary Atresia
NCT042725152 locations